• Citer

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

par Naumann, Robert Wendel;Hollebecque, Antoine;Meyer, Tim;Devlin, Michael John;Oaknin, Ana;Kerger, Joseph ;López-Picazo, José María;Machiels, Jean Pascal;Delord, Jean Pierre;Evans, Thomas Ronald Jeffrey;Boni, Valentina;Calvo, Emiliano;Topalian, Suzanne S.L.;Chen, Tian;Soumaoro, Ibrahima;Li, Bin;Gu, Junchen;Zwirtes, Ricardo;Moore, Kathleen K.N.
Référence Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37, 31, page (2825-2834)
Publication Publié, 2019-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
Auteur:	Naumann, Robert Wendel; Hollebecque, Antoine; Meyer, Tim; Devlin, Michael John; Oaknin, Ana; Kerger, Joseph; López-Picazo, José María; Machiels, Jean Pascal; Delord, Jean Pierre; Evans, Thomas Ronald Jeffrey; Boni, Valentina; Calvo, Emiliano; Topalian, Suzanne S.L.; Chen, Tian; Soumaoro, Ibrahima; Li, Bin; Gu, Junchen; Zwirtes, Ricardo; Moore, Kathleen K.N.
Informations sur la publication:	Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37, 31, page (2825-2834)
Statut de publication:	Publié, 2019-11
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:1527-7755
	info:doi/10.1200/JCO.19.00739
	info:scp/85074309329
	info:pmid/31487218